Sulindac sulfone, Modulates beta-catenin-mediated effects (TBI1122)

$90.00$324.00

Modulates beta-catenin-mediated effects

SKU: TBI1122 Category:
SKUStock SIZE (mg) PriceQuantity
TBI1122-5MG Yes 5 MG $90.00
spinner
TBI1122-25MG Yes 25 MG $324.00
spinner

Description

Product Details

Formal Name: (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfonyl)benzylidene]indene-3-acetic acid

Molecular Formula: C20H17FO4S

Formula Weight: 372.41

CAS Number: 59864-04-9

Purity: >98%

Formulation: powder

Solubility: Soluble in DMSO (up to 25 mg/ml).

Storage: RT

Stability: ≥ 2 years.

 

Applications

Modulates beta-catenin-mediated effects

 

Functions

Metabolite of the cyclooxygenase inhibitor sulindac that induces apoptosis via inhibition of type 5 phosphodiesterases. Sulindac sulfone does not inhibit cyclooxygenase at physiological concentrations but does inhibit K-ras-dependent cyclooxygenase-2 expression in colon cancer cells.

 

Application Procedures

First dissolved in DMSO (up to 25 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 1 week.

Additional information

SIZE (mg)

25 MG, 5 MG

Reviews

There are no reviews yet.


Be the first to review “Sulindac sulfone, Modulates beta-catenin-mediated effects (TBI1122)”